Kripps Digestive Support for Healthy G.I. Tract Function
Natural health product licensed in Canada
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| bêta-D-galactoside galactohydrolase Source : Aspergillus flavus var. oryzae - En entier | 9,000 FCC ALU | Not calculated |
| 1-Carboxy-N,N,N-chlorure de triméthylméthanaminium Source : Beta vulgaris - Racine | 330 mg | Not calculated |
| Lactobacillus rhamnosus Source : Cellule entière | 2,500,000,000 ufc | Not calculated |
| Bifidobacterium longum subsp. longum Source : Bifidobacterium longum subsp. longum - Cellule entière | 2,500,000,000 ufc | Not calculated |
Non-medicinal ingredients
Inuline, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Quantity Unit TBA | 3 Time Unit TBA |
Uses authorised in Canada
Digestive enzyme. Digestive enzyme/lactase to assist in the digestion of foods containing lactose. Probiotics that temporarily modify gut flora. Source of probiotics.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Headaches, heartburn, bloating and hypersensitivity (e.g. allergy) have been known ot occur; in which case, discontinue use. Nausea, vomiting, and diarrhoea have been known to occur, in which case discontinue use (and consult a health care practitioner).
- Contre-indications
Do not use if pregnant or breastfeeding. Do not use if you have an immune-compromised condition (e.g. AIDS, lymphoma, patients undergoing long-term corticosteroid treatment).
- Précautions et mises en garde
Consult a health care practitioner prior to use if you have diabetes or galactosemia. Discontinue use and consult a health care practitioner if symptoms persist or worsen. Discontinue use and consult a health care practitioner if symptoms of digestive upset (e.g. diarrhea) occur, worsen, or persist beyond 3 days. Do not use if you are experiencing nausea, fever, vomiting, bloody diarrhea or severe abdominal pain. Consult a health care practitioner prior to use if you have cardiovascular disease. If you have a gastrointestinal lesion/ulcer, are taking an anticoagulant/blood thinner, anti-inflammatory or antibiotic, or are having surgery, consult a health care practitioner prior to use.
Product record
- Licence holder
- Kripps Pharmacy Ltd.
- NPN or DIN-HM
- 80042586
- Status
- Inactive licence
- Licence date
- 31 May 2013
- Revision date
- Not provided
- Form
- Capsule, enrobage gélatine
- Route of administration
- Orale
- Application type
- Non traditionnelle
Source
Official Health Canada record, licence 80042586
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.